METTL3 and glioblastoma: In GBM, Cui et al.60 reported that consistent with the increased m6A levels during the differentiation of GSCs, overexpression of wild-type METTL3, but not a catalytically inactive mutant of METTL3, significantly promoted differentiation of GSCs and inhibited the self-renewal and proliferation of GSCs.